Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664079 · ClinicalTrials.gov registry record
Thyroid Hormones in Critically Ill Children
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- 22
- Enrollment target
NCT00664079: Clinical Trial study, sponsored by Children's Hospital of Philadelphia.
NCT00664079 is a clinical trial that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00664079 was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Thyroid hormones are substances naturally made by the body and are important to many of your body's basic functions such as breathing and brain function. We are investigating whether or not these hormones are at lower levels in critically ill children which could lead to further health problems. We hope to get a better understanding of hormone levels and their effects on critically ill children to better help other children in the future.
Interventions
- OTHER Blood draws
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-12 |
Why NCT00664079 stopped before completion
NCT00664079 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood draws is the first listed.
NCT00664079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00664079 about?
NCT00664079 is a clinical study titled "Thyroid Hormones in Critically Ill Children". Thyroid hormones are substances naturally made by the body and are important to many of your body's basic functions such as breathing and brain function. We are investigating whether or not these hormones are at lower levels in critically ill children which could lead to further health problems. We ...
What is the current status of trial NCT00664079?
This trial is currently terminated. The enrollment target is 22 participants. The study started on 2005-10. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00664079?
The interventions under investigation include: Blood draws (OTHER).
Who is sponsoring clinical trial NCT00664079?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia